alphaveALIVUS₹1,390.00

Alivus Life Sciences Ltd.

₹ CrorePeersDIVISLAB AARTIDRUGS AKUMS AGARWALEYE APLLTD ADVENZYMES AARTIPHARM CORONA

View

In ₹ Crore except Per Share 12 Months Ending	FY22 31/03/2022	FY23 31/03/2023	FY24 31/03/2024	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	584.6	774.9	795.0	795.0
+ Capital Work-in-Progress	91.7	49.4	101.2	101.2
+ Other Intangibles	10.4	5.7	10.1	10.1
+ Intangibles under Development	—	12.3	4.8	4.8
+ Non-current Investments	0.1	0.1	0.1	0.1
+ Other Non-current Financial Assets	5.6	8.2	11.0	11.0
Non-current Financial Assets	5.6	8.3	11.1	11.1
+ Other Non-current Assets	—	1.3	—	—
Total Non-current Assets	706.4	851.8	934.4	934.4
Current Assets
+ Inventories	516.2	604.2	666.6	666.6
+ Trade Receivables	673.5	806.8	765.4	765.4
+ Cash & Cash Equivalents	512.2	283.8	301.4	301.4
+ Other Bank Balances	0.0	25.6	0.2	0.2
+ Other Current Financial Assets	5.9	70.9	90.4	90.4
Current Financial Assets	1,191.6	1,187.1	1,157.4	1,157.4
+ Other Current Assets	56.8	59.1	92.0	92.0
Total Current Assets	1,764.6	1,850.3	1,916.0	1,916.0
Total Assets	2,471.0	2,702.1	2,850.4	2,850.4
Equity
+ Equity Share Capital	24.5	24.5	24.5	24.5
+ Other Equity / Reserves	2,029.8	2,113.7	2,307.8	2,307.8
Equity — Owners of Parent	2,054.3	2,138.2	2,332.3	2,332.3
Total Equity	2,054.3	2,138.2	2,332.3	2,332.3
Liabilities
+ Provisions — Non-current	—	—	15.8	15.8
+ Deferred Tax Liabilities	31.5	42.4	48.8	48.8
Non-current Liabilities	32.7	59.5	79.3	79.3
+ Provisions — Current	14.4	15.5	12.0	12.0
+ Other Current Liabilities	3.4	29.7	15.4	15.4
Current Liabilities	384.0	504.4	438.8	438.8
Total Liabilities	416.7	563.9	518.1	518.1
Total Equity & Liabilities	2,471.0	2,702.1	2,850.4	2,850.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY24 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.